aluminum sulfate has been researched along with Hepatitis B in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 7 (58.33) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bogans, J; Dekhtyar, Y; Dishlers, A; Lieknina, I; Ose, V; Petrovskis, I; Pumpens, P; Renhofa, R; Skrastina, D | 1 |
Shi, Y; Wen, Y | 1 |
Li, D; Sun, HX; Xie, Y | 1 |
Dixit, VK; Pandey, RS | 1 |
Dixit, VK; Karwasara, VS; Tomar, P | 1 |
Chaurasiya, A; Dixit, VK; Kumar, A; Maheshwari, C; Pandey, RS; Prasad, GB; Selvam, DT | 1 |
Burger, M; Chen, D; Chu, Q; Osorio, JE; Payne, LG; Zuleger, CL | 1 |
Comanita, L; Davis, HL; Weeratna, R | 1 |
Birkett, AJ; Calvo-Calle, JM; Corado, ML; Maier, C; Nardin, EH; Oliveira, GA; Sarpotdar, P; Schmidt, A; Thornton, GB; Wetzel, K | 1 |
Davis, HL; Engle, RE; Ma, X; McCluskie, MJ; Payette, PJ; Purcell, RH; Shapiro, M; Weeratna, RD | 1 |
Contorni, M; Morandi, M; Traquina, P; Van Nest, G | 1 |
Davis, HL; McCluskie, MJ; Payette, PJ; Weeratna, RD | 1 |
1 review(s) available for aluminum sulfate and Hepatitis B
Article | Year |
---|---|
Alum: an old dog with new tricks.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Hepatitis B; Humans; Inflammasomes; Neoplasms; NLR Family, Pyrin Domain-Containing 3 Protein; Vaccines | 2016 |
1 trial(s) available for aluminum sulfate and Hepatitis B
Article | Year |
---|---|
Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes.
Topics: Adolescent; Adult; Alum Compounds; Amino Acid Sequence; Animals; Antibodies, Protozoan; Double-Blind Method; Epitopes; Hepatitis B; Hepatitis B Core Antigens; Humans; Interferon-gamma; Malaria Vaccines; Malaria, Falciparum; Middle Aged; Molecular Sequence Data; Plasmodium falciparum; Protozoan Proteins; T-Lymphocytes; Vaccines, Synthetic; Virion | 2004 |
10 other study(ies) available for aluminum sulfate and Hepatitis B
Article | Year |
---|---|
Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Female; Freund's Adjuvant; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Vaccines; Hepatitis B virus; Immunity, Humoral; Immunization; Lipid A; Lipids; Mice, Inbred BALB C; Nanoparticles; Silicon Dioxide | 2014 |
Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Cell Proliferation; Cytokines; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B Vaccines; Immunoglobulin G; Killer Cells, Natural; Mice; Platycodon; Saponins; Spleen; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Triterpenes; Vaccines, Synthetic | 2009 |
Evaluation of ISCOMs for immunization against hepatitis B.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Cell Proliferation; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis Antibodies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Immunity, Cellular; Immunity, Humoral; Interferon-gamma; Interleukin-2; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Recombinant Proteins; Spectrometry, Fluorescence | 2009 |
Development characterizations and evaluation of Poly(-ε-caprolactone)-based microspheres for hepatitis B surface antigen delivery.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Calorimetry, Differential Scanning; Circular Dichroism; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Immunity, Cellular; Immunoglobulin G; Injections, Intramuscular; Interferon-gamma; Interleukin-2; Mice; Mice, Inbred BALB C; Microspheres; Polyesters | 2011 |
Non-ionic surfactant vesicles mediated transcutaneous immunization against hepatitis B.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Administration, Topical; Alum Compounds; Animals; Cholera Toxin; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunity, Mucosal; Immunization; Immunoglobulin G; Liposomes; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Skin; Surface-Active Agents; Th1-Th2 Balance | 2011 |
Immune responses to hepatitis B surface antigen following epidermal powder immunization.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; CpG Islands; Cytokines; DNA; Dose-Response Relationship, Immunologic; Epidermis; Female; Hepatitis B; Hepatitis B Surface Antigens; Immunoglobulin G; Mice; Mice, Inbred BALB C; Vaccines | 2003 |
CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB/c mice.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; CpG Islands; Female; Hepatitis B; Hepatitis B Surface Antigens; Mice; Mice, Inbred BALB C; Oligonucleotides; Vaccines | 2003 |
Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Oligodeoxyribonucleotides; Pan troglodytes; Vaccines, DNA; Vaccines, Synthetic | 2006 |
MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; CHO Cells; Cricetinae; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Male; Papio; Polysorbates; Squalene; Time Factors; Vaccines, Synthetic | 1996 |
Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Cholera Toxin; Disease Models, Animal; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Immunity, Mucosal; Immunization, Secondary; Mice; Mice, Inbred BALB C; Oligodeoxyribonucleotides; T-Lymphocytes, Cytotoxic; Th1 Cells; Th2 Cells; Vaccines, Synthetic | 2002 |